NTRK1 and neoplasm: AXL, a transmembrane receptor and a member of the TAM family of receptor tyrosine kinases, is implicated in many steps of the metastatic cascade and has emerged as a promising therapeutic target for many tumours, including lung cancer [1,2,3].